Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
Sponsor: The Third People's Hospital of Chengdu
Summary
The non-invasive evaluation of liver steatosis and fibrosis with FibroScan is a routinely procedure in clinical practice for people with obesity. However, there are still considerable uncertainties regarding the potential influence of confounding factors and the optimal application of cut-off values for obesity. The goal of this observational study is to learn about the optimal application of cut-off values of for Chinese people with obesity.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2023-10-24
Completion Date
2025-03-31
Last Updated
2024-12-06
Healthy Volunteers
Not specified
Conditions
Interventions
FibbroScan and biopsy
In individuals with obesity, a biopsy is performed within a week after undergoing an FibroScan examination.
Locations (1)
The Third People's Hospital of Chengdu
Chengdu, Sichuan, China